Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
176.98
+3.04 (+1.75%)
Official Closing Price
Updated: 4:10 PM EDT, May 20, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,516,024
Open
174.85
Bid (Size)
176.98 (1)
Ask (Size)
177.00 (14)
Prev. Close
173.94
Today's Range
174.05 - 177.16
52wk Range
155.72 - 186.69
Shares Outstanding
2,628,679,824
Dividend Yield
2.28%
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
ImmixBio's Lead Candidate Shows Improved Survival Over FDA-Approved Soft Tissue Cancer Drug
May 20, 2022
Via
Benzinga
What Are Whales Doing With Johnson & Johnson
May 19, 2022
Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
Performance
YTD
+3.17%
+3.17%
1 Month
-3.48%
-3.48%
3 Month
+9.83%
+9.83%
6 Month
+10.82%
+10.82%
1 Year
+3.52%
+3.52%
More News
Read More
Thoughts For Thursday: Ugly and Uglier
May 19, 2022
Via
Talk Markets
3 Safe Stocks to Buy As We Head For a Recession
May 19, 2022
Via
Talk Markets
Sector Rotation And 9 Stocks To Watch During A Recession
May 18, 2022
Via
Benzinga
IndyGeneUS AI Awarded Grant Funding through QuickFire Challenge
May 12, 2022
Via
PRLog
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
5 Stocks to Buy for the Coming Recession
May 18, 2022
Via
InvestorPlace
Psychedelics Atai Life Sciences: Optimizing Drug Development By Avoiding Big Pharma's Past Missteps
May 18, 2022
Via
Benzinga
SciSparc Reports Developing Cannabinoids Based Acute Pain Relief Alternative To Help Counter Opioid Crisis
May 18, 2022
Via
Benzinga
8 Analysts Have This to Say About Johnson & Johnson
May 17, 2022
Via
Benzinga
Point of Care Diagnostics Market Research Insight 2022| Key Players are Abbott Laboratories, Nova Biomedical, Chembio Diagnostic Systems, Inc., Danaher Corporation, Ekf Diagnostics Holdings Plc, Werfenlife, S.A., Johnson & Johnson Services, Inc., Hoff
May 17, 2022
Via
iCrowdNewswire
Dollar Gains Traction As Fed Aims To Tame Inflation
May 17, 2022
Via
Talk Markets
Inflation May Have Peaked: What to Do Now
May 16, 2022
Via
InvestorPlace
Johnson & Johnson Stock: A Rare Bright Spot in the Market
May 14, 2022
Via
InvestorPlace
Wall Street Extends Weekly Losing Streak Despite Upbeat Session
May 13, 2022
Via
Talk Markets
Biden Says US Ready To Share COVID-19 Vaccine Related Technology
May 13, 2022
Via
Benzinga
White House Says Currently No Plans To Share COVID-19 Shots With North Korea Battling Outbreak
May 13, 2022
Via
Benzinga
Read Why HC Wainwright Lowered Price Target On This Small Biotech Stock
May 12, 2022
Via
Benzinga
Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco
May 11, 2022
Via
Benzinga
Tuesday Talk: The Rough Ride Continues
May 10, 2022
Via
Talk Markets
Let Dividend Stocks Protect You From The Bear Market
May 10, 2022
Via
Talk Markets
This Is What Whales Are Betting On Johnson & Johnson
May 09, 2022
Via
Benzinga
4 Blue-Chip Stocks to Buy for May 2022
May 09, 2022
Via
InvestorPlace
9 Health Care Stocks With Whale Alerts In Today's Session
May 06, 2022
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Friday, May 6
May 06, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.